MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
2023: Top 20 Genomics Companies in the World
Illumina, Inc. (NASDAQ: ILMN)
Organization & Developments: Illumina
*Developments: Illumina
Parents
Organization & Developments: Illumina
Children
*Automated sample processing and next-generation sequencing technology for COVID-19 testing that will be scaled up.
*Developments: Illumina (Archives 2015-2016)
*Its high-throughput capacity can be expanded to 48,000 tests per day. Upon receipt of samples at the laboratory, the company can process results for the Illumina COVIDSeq test within 24 hours.
2017: FDA_MiSeq Preventive Maintenance & Repair Service
2017: Illumina & IBM Watson form cancer genomics partnership
2017: Illumina Introduces New Sequencers to Help Reduce Whole Genome Analysis to $100
2017: NIH_Annual Service Agreement on Illumina Equiment
2017: NIH_Illumina NextSeq 550 Sequencing System Sequencer Upgrade
2017: U.S. Army_Award: W81XWH-17-P-0089/Illumina Reagents
2017: U.S.Army_Notice of Intent to Soule Source for Illumina Reagents
2017: VA_65-- Illumina Reagents PLMS
2017: VA_Illumina Reagents
2018: Illumina, Bristol-Myers Squibb Partner on Companion Dx Development for Immunotherapy
2018: NIDDK_Whole Exome Sequencing
2018: NIH_NCATS_Transcriptome analysis for stem cell differentiation from bulk RNA sequencing to single cell RNA sequencing
2018: U.S. Army_USAMRMC_Illumina_Preventative Maintenaince
2019: CDC_Illuminia NextSeq 550 Sequencing System
2019: Genetic Testing Companies Take DNA Tests To A Whole New Level
2019: Illumina and Qiagen ink long-term IVD diagnostics partnership_seekingalpha.com
2020: Illumina debuts next-gen sequencing test for COVID-19
2020: Illumina Snares First FDA Emergency Use Authorization for NGS-Based SARS-CoV-2 Test
2020: Illumina, AnchorDx to Develop Genomic Cancer Tests for Chinese Market
2020: Illumina: A Growth Leader In The Genomic Revolution
2020: Illumina: Missed March Opportunity, Good Long-Term Prospects
2020: JPM: Roche, Illumina unveil 15-year cancer diagnostic tie-up
2021: Illumina, Sequoia Capital launch genomics startup incubator in China
2021: Illumina: Gene Sequencing Leader In The Golden Age Of Genetics
2022: Chemistry X, Infinity, GRAIL: The New Illumina Is A Buy_seekingalpha.com
2022: Illumina joins with AstraZeneca on AI-driven drug discovery project
2022: Illumina pitches $200 genomes with new line of DNA sequencers
2022: The Era of Fast, Cheap Genome Sequencing Is Here_Tiktok
2023: Illumina delivers first NovaSeq X Plus sequencer to the Broad Institute_yahoo
2023: Illumina Remains A Sell After 2023 Guidance_ seekingalpha.com
2023: Illumina: DNA giant in troubled waters
2023: Is Illumina Inc (ILMN) a Hidden Value Trap? A Comprehensive Analysis_ yahoo
2024: Illumina announces strategy to accelerate value creation
2024: Illumina Sees The Light: GRAIL Is Gone, Focus Restored (Rating Upgrade)_ seekingalpha.com
2024: Illumina: One Of The Most Hated Stocks In Healthcare Is Looking Like A Strong Buyseekingalpha.com
2024: Illumina: Stagnant Revenues And Shrinking Margins Amidst Rising Competition
2024: Illumina: Volatility Galore, But Not Much Prospect Of Progress In 2024_seekingalpha.com
2024: Revisiting Illumina
2025: Illumina Unveils Spatial Technology Days Before AGBT Meeting
2025: Illumina: Navigating Headwinds As China Bans Instruments And Roche Enters The NGS Race_ seekingalpha.com
Jumps
*Organization: Illumina
Developments: Illumina (Archives 2011-2014)